Jazz Pharmaceuticals plc - 8-K Filing
Jazz Pharmaceuticals' Executive Vice President and Chief Commercial Officer Samantha Pearce plans to retire by June 30, 2027. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $JAZZ